Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
Tweet Send to a Friend
Canaccord Genuity analyst Mark Massaro reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $40.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
